Cost-effectiveness of 13-valent pneumococcal conjugate vaccination in Mongolia

This study evaluates the cost-effectiveness and budget impact of introducing PCV13 compared to no PCV vaccination in Mongolia.

a:1:{i:0;s:45:"https://doi.org/10.1016/j.vaccine.2016.12.070";}

Sundaram N, Chen C, Yoong J, Luvsan M, Fox K, Sarankhuu A et al. Cost-effectiveness of 13-valent pneumococcal conjugate vaccination in Mongolia. Journal of Vaccine. 2017;35(7):1055-1063. doi: 10.1016/j.vaccine.2016.12.070